Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 2 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 49 Breast Neoplasms 39 Ovarian Neoplasms 35 Triple Negative Breast Neoplasms 24 Endometrial Neoplasms 20 Stomach Neoplasms 19 Squamous Cell Carcinoma of Head and Neck 17 Lung Neoplasms 17 Fallopian Tube Neoplasms 17 Esophageal Squamous Cell Carcinoma 15 Esophageal Neoplasms 15 Neoplasms 14 Neoplasm Metastasis 14 Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Uterine Cervical Neoplasms 12 Carcinoma, Ovarian Epithelial 10 Head and Neck Neoplasms 7 Recurrence 6 Colorectal Neoplasms 6 Carcinoma 6 Adenocarcinoma 5 Uterine Neoplasms 4 Small Cell Lung Carcinoma 4 Oropharyngeal Neoplasms 4 Melanoma 4 Carcinoma, Transitional Cell 4 Carcinoma, Squamous Cell 4 Advanced Solid Tumors 4 Adenocarcinoma Of Esophagus 4 Peritoneal Neoplasms 3

Interventions

Drug Therapy 4 Pemetrexed 3 Carboplatin 3 osimertinib 2 Radiotherapy 2 toripalimab 1 tislelizumab 1 sugemalimab 1 spartalizumab 1 sintilimab 1 pembrolizumab 1 cemiplimab 1 aflutinib 1 Vinorelbine 1 Radiosurgery 1 Platinum 1 Paclitaxel 1 Gemcitabine 1 Docetaxel 1 Cisplatin 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × NSCLC × Paclitaxel × Clear all

NCT06576635 2026-01-20

LUNG-05

University of Illinois at Chicago

Phase NA Recruiting

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡